SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The national debt has increased every year for the past ten years, and interest expenses have remained fairly stable due to low interest rates and the perceived low risk of U.S. government default, according to the U.S. Treasury Fiscal Data. This coin is a parody coin about the debt crises in the US and to highlight various aspects about this crises in a humouros way to the people on solana. $USNDC

UnitedStates National Debt Coin

UnitedStates National Debt Coin ($USNDC.X) is trending as community members highlight positive sentiment and strong buying activity. Conversations suggest a potential breakout, with many urging others to buy before a significant price increase. Some users are also discussing the coin's activity and tracking via Phantom wallet.

Fwog

Fwog is trending as the community rallies behind the meme coin, with many believing it's undervalued and poised for significant gains. Discussions highlight its potential to be the next breakout meme coin on the Solana network, drawing comparisons to other successful projects. Some investors are noting the strong community and unique artwork as key drivers for its future success.

|The Artificial Superintelligence (ASI) Alliance is the world’s largest open-source initiative dedicated to decentralized Artificial General Intelligence (AGI). Formed in April 2024, the ASI Alliance unites SingularityNET, Fetch.ai, and Ocean Protocol, with CUDOS joining as a network member shortly after. The ASI Alliance was established through a community-approved tokenomic merger—combining $AGIX, $FET, and $OCEAN into a single token: $FET. This unified token underpins a collaborative framework designed to scale open-source AI and stand as the largest open-sourced, independent entity in AI research and development. The Alliance is committed to accelerating the advancement of decentralized Artificial General Intelligence (AGI) and, ultimately, Artificial Superintelligence (ASI). It provides a robust, open-source innovation stack, empowering developers, enterprises, and researchers globally to build ethical, scalable, and groundbreaking AI solutions. This ensures that advanced intelligence remains a shared, accessible resource, fostering innovation beyond centralized systems and promoting a future where AI benefits all.

Fetch.ai

Fetch.ai is trending as the community anticipates potential gains, drawing attention to its connection with AI and autonomous agent technology. Grok's (Elon Musk AI) recommendations have fueled speculation about substantial returns, with community members actively discussing potential catalysts and real-world applications. The broader narrative focuses on Fetch.ai's role in the AI and crypto space, with some suggesting it's undervalued despite recent market fluctuations.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is trending as the community discusses the company's recent earnings, potential acquisitions, and the competitive landscape with new drugs entering the hereditary angioedema (HAE) market. Community members are debating the impact of competitor Ionis's newly approved drug, Dawnzera, on Biocryst's market share, while also speculating about a potential buyout. The stock's price action, especially in light of positive financial results, remains a key point of contention and frustration among investors.

Mamo turns what used to be complex into easy, human-first routines.  It works quietly in the background, finding smart opportunities for your money while you focus on what matters in your life. Think of Mamo as your knowledgeable friend who understands how to help your money grow and explain everything in plain language.  Behind the scenes, Mamo applies proven strategies and real-time data to optimize your portfolio, reinvest earnings when conditions are right, and adapt to market shifts — all with your approval and full transparency.  No noise. No confusion. Just calm, steady growth.

Mamo

Mamo is trending as the community discusses its potential following a significant price run and subsequent pullback, with attention focused on the anticipated launch of The Base App in Q4. Some community members are speculating on price targets and the potential for substantial user growth once the app is released, while others express concerns about recent price action.

Solana Street Bets is not just a memecoin; it's a symbol of creativity, humor, and the power of a united community. Inspired by the infamous /wallstreetbets subreddit. Solana Street Bets is here to put respect on the Wall St originated memes in the industry. Solana Street Bets is a decentralized Solana meme coin inspired by the infamous /wallstreetbets subreddit.

SatoshiStreetBets

SSB.X is trending as community members highlight a specific associated token, $PUPU.X, with many claiming "dips are getting bought instantly" and momentum is building for a breakout. The project's connection to the broader SatoshiStreetBets community and a comparison to previous meme coin successes like PEPE are also driving interest. Bullish community members suggest that the "rocket fuel is stacking" for the project.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is trending as investors discuss the company's recent acquisition of anti-coagulant assets, including a Pre-Phase-2 drug, which expands their pipeline. Community members are noting the bullish setup, breakout energy, and building momentum, anticipating a potential upside breakout. The company's advancements in cardiovascular therapeutics and potential impact on the anticoagulation market are also being highlighted.

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

Biogen Inc

Biogen ($BIIB) is trending as traders weigh the impact of a recent FDA roadblock for its Spinraza drug amid ongoing European regulatory reviews. The community is also actively discussing potential support trendlines and call option strategies. Positive sentiment stems from recent EU approval for Zurzuvae, a postpartum depression drug.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending as investors discuss the company's financial runway and potential partnerships, particularly the existing one with VW. Community members are actively sharing concerns around build quality and service experiences, while also expressing excitement for the upcoming R2 model and its potential impact. Discussions also involve speculation on sales numbers and the stock's potential breakout points.

Arbitrum is one of the leading Ethereum scaling solutions bringing cheap transactions to tens of thousands of users in an environment that feels very similar to Ethereum. It is an optimistic rollup and the leading L2 in terms of TVL. Some of the largest dApps live on Arbitrum include GMX, Radiant, Uniswap V3, and Gains Network.

Arbitrum

Arbitrum is trending amidst discussions about potential price reversals and bearish sentiment, with some traders highlighting order book structures suggesting a possible stall. However, there's also excitement around Arbitrum's integrations, such as decentralized key management by Lit Protocol and the embeddable Arbitrum Bridge. The community is weighing the potential for accumulation against the backdrop of wider crypto market volatility and the historical performance of altcoins.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Fortinet's Geographic Mix Improves: Can EMEA Drive More Upside?

FTNT's EMEA revenues rise 18% y/y in Q2 2025, strengthening its global pipeline and reducing reliance on North America.

Zscaler, Inc. (ZS) Is a Trending Stock: Facts to Know Before Betting on It

Zacks.com users have recently been watching Zscaler (ZS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Gorilla Swings 13% Higher on $1.4B Freyr Deal in Southeast Asia

GRRR surges 13% after sealing a $1.4B deal with Freyr to build and run AI data centers across Southeast Asia.

Can FTNT Stock Recover From YTD Drop on AI Security Push? How to Play

Fortinet stock declines 15.6% YTD despite AI expansion efforts. Strong SASE momentum and raised guidance suggest holding for recovery.

Will FTNT's Heavy Infrastructure Build-Out Drive Next Phase of Growth?

Fortinet ramps up infrastructure spending to fuel cloud-first growth, boost billings and strengthen its competitive edge.

PANW's Platform Strategy Builds Momentum: Can it Hit $15B ARR Target?

Palo Alto Networks gains momentum with platformization, landing mega-deals as NGS ARR climbs toward its $15B target.

Unlocking Zscaler (ZS) International Revenues: Trends, Surprises, and Prospects

Explore Zscaler's (ZS) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

Investors Heavily Search Zscaler, Inc. (ZS): Here is What You Need to Know

Zscaler (ZS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

PANW's SASE ARR Hits $1.3B: Is Prisma Browser the Key Driver?

Palo Alto Networks' SASE ARR surges 35% to $1.3B, fueled by rapid Prisma Browser adoption.

Zscaler Q4 Earnings Beat: Will Strong Guidance Lift the Stock Higher?

ZS' Q4 earnings soar, beating estimates with 21% revenue growth and initiates strong FY26 guidance.

Zscaler, Inc. engages in the provision of a cloud-based internet security platform. It offers Zero Trust Exchange, Zscaler Client Connector, Zscaler Internet Access, Zscaler Private Access, Zscaler B2B, Zscaler Cloud Protection, and Zscaler Digital Experience. The company was founded by Jagtar Singh Chaudhry and K. Kailash in September 2007 and is headquartered in San Jose, CA.

Zscaler Inc

Will the U.S. government shut down in 2025? 
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	$0.86	--	--	N/A
Q4 '25	$0.80	$0.89	11.25%	BEAT
Q3 '25	$0.76	$0.84	11.18%	BEAT
Q2 '25	$0.69	$0.78	13.49%	BEAT
Q1 '25	$0.63	$0.77	22.75%	BEAT

ZS
Zscaler Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q4 '25

Historical Earnings

Latest ZS News

ZS Zscaler Inc